Synthesis and receptor binding affinity of cholecystokinin receptor ligands: 2-and 1-indolyl derivatives of PD134308. 1996

G Araldi, and D Donati, and B Oliosi, and A Ursini, and F van Amsterdam, and B Natalini, and R Pellicciari, and G Tarzia
Glaxo Wellcome S.p.A., Medicines Research Centre, Verona, Italy.

The synthesis of two "dipeptoids" structurally related to the CCK-B antagonist CI-988 (PD134308) is described. The 2- and 1-indolyl derivatives 4a, b were prepared in order to define the role of the tryptophan moiety in this series of "dipeptoids". They were evaluated as competitors in the binding of [3H]-CCK8S on guinea pig brain CCK-B receptors.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008297 Male Males
D008536 Meglumine 1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium. Methylglucamine
D011949 Receptors, Cholecystokinin Cell surface proteins that bind cholecystokinin (CCK) with high affinity and trigger intracellular changes influencing the behavior of cells. Cholecystokinin receptors are activated by GASTRIN as well as by CCK-4; CCK-8; and CCK-33. Activation of these receptors evokes secretion of AMYLASE by pancreatic acinar cells, acid and PEPSIN by stomach mucosal cells, and contraction of the PYLORUS and GALLBLADDER. The role of the widespread CCK receptors in the central nervous system is not well understood. CCK Receptors,Caerulein Receptors,Cholecystokinin Octapeptide Receptors,Cholecystokinin Receptors,Pancreozymin Receptors,Receptors, CCK,Receptors, Caerulein,Receptors, Pancreozymin,Receptors, Sincalide,Sincalide Receptors,CCK Receptor,CCK-4 Receptors,CCK-8 Receptors,Cholecystokinin Receptor,Receptors, CCK-4,Receptors, CCK-8,Receptors, Cholecystokinin Octapeptide,CCK 4 Receptors,CCK 8 Receptors,Octapeptide Receptors, Cholecystokinin,Receptor, CCK,Receptor, Cholecystokinin,Receptors, CCK 4,Receptors, CCK 8
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006727 Hormone Antagonists Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. Antagonists, Hormone
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G Araldi, and D Donati, and B Oliosi, and A Ursini, and F van Amsterdam, and B Natalini, and R Pellicciari, and G Tarzia
March 2009, Bioorganic & medicinal chemistry letters,
G Araldi, and D Donati, and B Oliosi, and A Ursini, and F van Amsterdam, and B Natalini, and R Pellicciari, and G Tarzia
May 1991, Journal of medicinal chemistry,
G Araldi, and D Donati, and B Oliosi, and A Ursini, and F van Amsterdam, and B Natalini, and R Pellicciari, and G Tarzia
April 2001, Bioorganic & medicinal chemistry,
G Araldi, and D Donati, and B Oliosi, and A Ursini, and F van Amsterdam, and B Natalini, and R Pellicciari, and G Tarzia
August 2015, Die Pharmazie,
G Araldi, and D Donati, and B Oliosi, and A Ursini, and F van Amsterdam, and B Natalini, and R Pellicciari, and G Tarzia
February 2014, Bioorganic & medicinal chemistry letters,
G Araldi, and D Donati, and B Oliosi, and A Ursini, and F van Amsterdam, and B Natalini, and R Pellicciari, and G Tarzia
February 2018, Bioorganic & medicinal chemistry letters,
G Araldi, and D Donati, and B Oliosi, and A Ursini, and F van Amsterdam, and B Natalini, and R Pellicciari, and G Tarzia
July 2004, Bioorganic & medicinal chemistry letters,
G Araldi, and D Donati, and B Oliosi, and A Ursini, and F van Amsterdam, and B Natalini, and R Pellicciari, and G Tarzia
February 2006, Bioorganic chemistry,
G Araldi, and D Donati, and B Oliosi, and A Ursini, and F van Amsterdam, and B Natalini, and R Pellicciari, and G Tarzia
April 1997, Farmaco (Societa chimica italiana : 1989),
G Araldi, and D Donati, and B Oliosi, and A Ursini, and F van Amsterdam, and B Natalini, and R Pellicciari, and G Tarzia
October 1991, Journal of medicinal chemistry,
Copied contents to your clipboard!